PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,618,000 | +57.2% | 67,767 | +128.4% | 0.08% | +29.0% |
| Q1 2019 | $1,029,000 | +414.5% | 29,667 | +459.8% | 0.06% | +675.0% |
| Q2 2018 | $200,000 | -65.5% | 5,300 | -55.5% | 0.01% | -69.2% |
| Q4 2017 | $579,000 | -80.8% | 11,900 | -78.6% | 0.03% | -83.0% |
| Q3 2017 | $3,009,000 | -6.8% | 55,700 | -3.1% | 0.15% | -10.5% |
| Q2 2017 | $3,229,000 | -22.0% | 57,500 | -45.6% | 0.17% | -10.5% |
| Q1 2017 | $4,142,000 | +467.4% | 105,700 | +195.2% | 0.19% | +478.8% |
| Q1 2016 | $730,000 | -51.5% | 35,812 | -9.6% | 0.03% | -36.5% |
| Q1 2015 | $1,504,000 | +300.0% | 39,633 | +206.8% | 0.05% | +160.0% |
| Q2 2014 | $376,000 | – | 12,918 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |